VCEL Vericel Corporation

17.44
0  0%
Previous Close 17.44
Open
Price To Book 7.42
Market Cap 765,813,351
Shares 43,911,316
Volume 8
Short Ratio
Av. Daily Volume 591,122

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b topline data released March 2016. Full data released April 2016
ixmyelocel-T
Stem cells - Dilated Cardiomyopathy
FDA Approval announced December 13, 2016 ahead of PDUFA date of January 3 2017.
MACI
Focal chondral cartilage defects in the knee.

Latest News

  1. Hedge Funds Have Never Been This Bullish On Vericel Corp (VCEL)
  2. BARDA to Fund NexoBrid Expanded Access Treatment Protocol for Thermal Burns
  3. Edited Transcript of VCEL earnings conference call or presentation 7-May-19 12:00pm GMT
  4. Vericel to Present at the 2019 UBS Global Healthcare Conference on Wednesday, May 22, 2019
  5. Surgeons to use product from Cambridge's Vericel on baby born without skin
  6. Were Hedge Funds Right About Dumping Vericel Corp (VCEL) ?
  7. Vericel (VCEL) Q1 2019 Earnings Call Transcript
  8. Vericel looks to market a gel for burns with new $142M licensing deal
  9. Vericel Reports First Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
  10. MediWound Enters into Exclusive License Agreement with Vericel for Commercial Rights to NexoBrid® in North America
  11. Vericel Enters into Exclusive License Agreement with MediWound for North American Rights to NexoBrid, a Biological Orphan Product for Debridement of Severe Thermal Burns
  12. Calculating The Intrinsic Value Of Vericel Corporation (NASDAQ:VCEL)
  13. Here’s What Hedge Funds Think About Vericel Corp (VCEL)
  14. Will Vericel (VCEL) Report Negative Earnings Next Week? What You Should Know
  15. Vericel to Report First-Quarter 2019 Financial Results on May 7, 2019
  16. Vericel to Present at Needham Healthcare Conference
  17. Market Trends Toward New Normal in Verizon Communications, Digital Turbine, Vericel, Capstead Mortgage, Paratek Pharmaceuticals, and CryoPort — Emerging Consolidated Expectations, Analyst Ratings
  18. Our Take On Vericel Corporation’s (NASDAQ:VCEL) CEO Salary
  19. What Makes Vericel (VCEL) a New Buy Stock
  20. Vericel to Present at Multiple Upcoming Investor Conferences